PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
-2.59%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$1.33B
AUM Growth
+$1.33B
(-5.3%)
Cap. Flow
+$73.5M
Cap. Flow
% of AUM
5.54%
Top 10 Holdings %
Top 10 Hldgs %
38.03%
Holding
288
New
61
Increased
32
Reduced
61
Closed
45
Top Buys
| 1 |
LivaNova
LIVN
|
$40.9M |
| 2 |
WM Technology
MAPS
|
$23.4M |
| 3 |
Seer Inc
SEER
|
$20.9M |
| 4 |
Cooper Companies
COO
|
$16.5M |
| 5 |
CANO
Cano Health, Inc.
CANO
|
$16.2M |
Top Sells
| 1 |
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
|
$54.7M |
| 2 |
Intellia Therapeutics
NTLA
|
$23.2M |
| 3 |
Organogenesis Holdings
ORGO
|
$21.3M |
| 4 |
Eli Lilly
LLY
|
$15.1M |
| 5 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$14.5M |
Sector Composition
| 1 | Healthcare | 82.38% |
| 2 | Consumer Staples | 1.98% |
| 3 | Technology | 1.76% |
| 4 | Industrials | 1.72% |
| 5 | Materials | 1.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Turning Point Brands
TPB
$1.79B
| $4.37M | 0.13% | 91,449 -9,610 | -10% | -$459K |
|
77
Definitive Healthcare
DH
$419M
| $4.28M | 0.13% | +100,000 | New | +$4.28M |
|
78
Celldex Therapeutics
CLDX
$1.47B
| $4.17M | 0.13% | 77,285 -27,771 | -26% | -$1.5M |
|
79
Nektar Therapeutics
NKTR
$568M
| $3.94M | 0.12% | +219,540 | New | +$3.94M |
|
80
Maravai LifeSciences
MRVI
$350M
| $3.8M | 0.12% | +77,500 | New | +$3.8M |
|
81
Corvus Pharmaceuticals
CRVS
$428M
| $3.55M | 0.11% | +734,268 | New | +$3.55M |
|
|
SNAX
82
DELISTED
Stryve Foods, Inc. Class A Common Stock
SNAX
| $3.08M | 0.09% | +575,000 | New | +$3.08M |
|
83
AstraZeneca
AZN
$248B
| $3M | 0.09% | +50,000 | New | +$3M |
|
84
Bausch Health
BHC
$2.74B
| $2.79M | 0.08% | +100,000 | New | +$2.79M |
|
85
Bionano Genomics
BNGO
$17.6M
| $2.75M | 0.08% | 500,000 -500,000 | -50% | -$2.75M |
|
86
Arcutis Biotherapeutics
ARQT
$1.86B
| $2.68M | 0.08% | 112,324 -1,737 | -2% | -$41.5K |
|
|
MRTX
87
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.65M | 0.08% | 15,000 -24,522 | -62% | -$4.34M |
|
88
Senti Biosciences
SNTI
$38.5M
| $2.54M | 0.08% | 255,700 +5,700 | +2% | +$56.7K |
|
89
Beam Therapeutics
BEAM
$1.66B
| $2.14M | 0.07% | 24,573 -427 | -2% | -$37.2K |
|
|
FRONU
90
DELISTED
Frontier Acquisition Corp. Units
FRONU
| $2.1M | 0.06% | 213,023 -3,685 | -2% | -$36.4K |
|
|
MDVL
91
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| $2.09M | 0.06% | 714,120 -648,264 | -48% | -$1.89M |
|
|
BLU
92
DELISTED
BELLUS Health Inc.
BLU
| $2.06M | 0.06% | +334,805 | New | +$2.06M |
|
93
Disc Medicine
IRON
$2.07B
| $2M | 0.06% | +494,400 | New | +$2M |
|
|
DALS
94
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
| $1.97M | 0.06% | +200,000 | New | +$1.97M |
|
|
ITCI
95
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.95M | 0.06% | +52,213 | New | +$1.95M |
|
|
IMGN
96
DELISTED
Immunogen Inc
IMGN
| $1.95M | 0.06% | 343,048 -346,001 | -50% | -$1.96M |
|
97
Immunocore
IMCR
$1.62B
| $1.85M | 0.06% | +50,000 | New | +$1.85M |
|
98
Cullinan Oncology
CGEM
$445M
| $1.84M | 0.06% | 81,418 -159,380 | -66% | -$3.6M |
|
99
Nuvation Bio
NUVB
$1.02B
| $1.77M | 0.05% | +178,403 | New | +$1.77M |
|
|
THRN
100
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
| $1.73M | 0.05% | +200,000 | New | +$1.73M |
|